Literature DB >> 31250408

Cholangioscopy-guided lithotripsy for difficult bile duct stone clearance in a single session of ERCP: results from a large multinational registry demonstrate high success rates.

Amit P Maydeo1, Rungsun Rerknimitr2, James Y Lau3, Abdulrahman Aljebreen4, Saad K Niaz5, Takao Itoi6, Tiing Leong Ang7, Jörg Reichenberger8, Dong Wan Seo9, Mohan K Ramchandani10, Benedict M Devereaux11, Jong Kyun Lee12, Mahesh K Goenka13, Randhir Sud14, Nam Q Nguyen15, Rakesh Kochhar16, Joyce Peetermans17, Pooja G Goswamy17, Matthew Rousseau17, Surya Prakash Bhandari1, Phonthep Angsuwatcharakon2, Raymond S Y Tang3, Anthony Y B Teoh3, Majid Almadi4, Yun Nah Lee18, Jong Ho Moon18.   

Abstract

BACKGROUND: Peroral cholangioscopy (POCS) can be useful for difficult bile duct stone clearance. Large prospective multinational data on POCS-guided lithotripsy for clearing difficult bile duct stones in a single session of endoscopic retrograde cholangiopancreatography (ERCP) are missing.
METHODS: Patients with difficult bile duct stones (defined as one or more of: largest stone diameter ≥ 15 mm, failed prior attempt at stone clearance, impacted, multiple, hepatic duct location, or located above a stricture) were enrolled at 17 centers in 10 countries. The principal endpoint was stone clearance in a single ERCP procedure using POCS. RESULTS : 156 patients underwent 174 sessions of POCS-guided electrohydraulic or laser lithotripsy. Stone clearance had failed in a previous ERCP using traditional techniques in 124/156 patients (80 %), while 32 /156 patients (21 %) were referred directly to POCS-guided therapy based on preprocedural assessment of the difficulty of stone clearance. In 101/156 patients (65 %), there were impacted stones. POCS-guided stone clearance was achieved in a single POCS procedure in 125 /156 patients (80 %, 95 % confidence interval [CI] 73 % - 86 %), and was significantly more likely for stones ≤ 30 mm compared with > 30 mm (odds ratio 7.9, 95 %CI 2.4 - 26.2; P = 0.002). Serious adverse events occurred in 3/156 patients (1.9 %, 95 %CI 0.4 % - 5.5 %), and included pancreatitis, perforation due to laser lithotripsy, and cholangitis (n = 1 each), all resolved within 1 week.
CONCLUSION: POCS-guided lithotripsy is highly effective for clearance of difficult bile duct stones in a single procedure and successfully salvages most prior treatment failures. It may also be considered first-line therapy for patients with difficult choledocholithiasis to avoid serial procedures. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2019        PMID: 31250408     DOI: 10.1055/a-0942-9336

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  4 in total

1.  Utility of the Novel SpyGlassTM DS II System and Laser Lithotripsy for Choledocholithiasis in Pregnancy.

Authors:  Ankit Dalal; Gaurav Patil; Nagesh Kamat; Rajen Daftary; Sehajad Vora; Amit Maydeo
Journal:  GE Port J Gastroenterol       Date:  2021-08-12

Review 2.  Endoscopic management of difficult common bile duct stones: Where are we now? A comprehensive review.

Authors:  Alberto Tringali; Deborah Costa; Alessandro Fugazza; Matteo Colombo; Kareem Khalaf; Alessandro Repici; Andrea Anderloni
Journal:  World J Gastroenterol       Date:  2021-11-28       Impact factor: 5.742

3.  Percutaneous transhepatic cholangioscopy using a single-operator cholangioscope (pSOC), a retrospective, observational, multicenter study.

Authors:  Christian Gerges; Alain García Vázquez; Andrea Tringali; Juan Manuel Verde; Tobias Dertmann; Eduardo Houghton; Alessandro Cina; Torsten Beyna; Federico Sylvestre Begnis; Margherita Pizzicannella; Mariano Palermo; Silvana Perretta; Guido Costamagna; Jacques Marescaux; Horst Neuhaus; Ivo Boškoski; Mariano Eduardo Giménez
Journal:  Surg Endosc       Date:  2021-01-04       Impact factor: 4.584

Review 4.  Difficult Biliary Stones: A Comprehensive Review of New and Old Lithotripsy Techniques.

Authors:  Edoardo Troncone; Michelangela Mossa; Pasquale De Vico; Giovanni Monteleone; Giovanna Del Vecchio Blanco
Journal:  Medicina (Kaunas)       Date:  2022-01-13       Impact factor: 2.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.